Search results for: 'channel cloud on rate 2023'

Frost and Sullivan expects 2023 to be the year of resilience. Businesses will face a range of challenges, including a global economic slowdown, supply chain bottlenecks, and geopolitical shocks. Organizations of all sizes and types will be compelled to find new areas for growth, despite an abrupt downturn in consumer demand. This study identifi...

New analysis from Frost & Sullivan's Digital Transformation program finds that the market for cloud contact centers continues to increase. The acceleration of omnichannel and digital transformation, coupled with the C-suite demands for stronger and swifter growth, is driving future technology acquisitions. Clear articulation of visionary perspectiv...

The care coordination workflow aims to optimize the entire value chain of patient care. The objective of this research service is to present a comprehensive analysis of the US care coordination software market, with respect to market potential and key market dynamics at play in the next 5 years. The regional scope of the analysis is the United Stat...

02 Feb 2017  |  Europe  |  Market Research

European Next-generation Sequencing Services Market, Forecast to 2023

Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

Infographics

×

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-changing Compa...

06 Feb 2018  |  Global  |  Market Research

Growth Opportunities in Clinical Trial Data Management and eClinical Solutions Market, Forecast to 2020

Digitization Presents Opportunities for Unified Cloud-based Platform Solutions to Optimize Clinical Trial Workflows

Infographics

×

Key Issues Addressed

The global clinical trial IT market is expected to grow from $2.63 billion in 2016 to $4.29 billion in 2020 at a compound annual growth rate (CAGR) of more than 13.0%. North America will continue to hold the largest market share (by revenue) in 2017, followed by Europe. Increasing clinical trial activities in the emerging Asia-Pacific markets and r...

The professional headset market will continue to experience notable growth rates due to the evolution of software-based communications and collaboration services and the need to improve worker productivity. The largest opportunity lies within professional headsets that offer PC USB connectivity and value-added features to optimize the software com...

Buy now, pay later (BNPL), also referred to as point of sale (PoS) installment loans, is a short-term financing option that enables consumers to spread out payments for purchases over a period of time. The increase in eCommerce activity during the COVID-19 pandemic brought along with it a strong interest in alternative spending options. BNPL, a sub...

11 Jul 2019  |  North America  |  Market Research

Growth Opportunities in the Global Radiology-as-a-Service Market, Forecast to 2023

Innovative Business Models Focusing on Operational, Clinical, and Financial Excellence Witnessing Growing Adoption, Due to Increasing Influence of Value-based Care and Sustainable Healthcare Initiatives in the Imaging Ecosystem

Infographics

×

This Growth Opportunity service presents an analysis of the emerging ‘servitization’ business models in the medical imaging industry. With healthcare systems gradually transitioning to value-based care, imaging vendors across the value chain are positioning themselves as partners in this journey through risk-sharing and outcome-based services, with...

14 Jan 2019  |  North America  |  Market Research

Growth Opportunities in the Global qPCR and dPCR Market, Forecast to 2023

Novel Applications in Oncology and Applied Sciences, Growing Research and Diagnostic Use in Developing Regions, and Automated Modular Workflows to Drive Growth

Infographics

×

Key Issues Addressed

Overview: PCR continues to be the gold standard for nucleic acid amplification by combining accuracy and efficacy that users across areas such as research, pharma & biotech, diagnostics as well as applied sciences depend upon. Such widespread usage continues to drive the industry, even protecting it to some extent from overall economic/market fluct...